Abstract CT247: FORTE: A phase 2 master protocol assessing plixorafenib for BRAF-altered cancers

Journal article

Peer reviewed

Karisa C. Schreck, Macarena I. de la Fuente, Jessica Rine, Irina Kline, Stacie Peacock Shepherd, Jordi Rodon, Rona Yaeger and Eric Sherman

Cancer research (Chicago, Ill.), Vol.85(8_Supplement_2), pp.CT247-CT247

2025-04-25

Metrics

1 Record Views

Title: Abstract CT247: FORTE: A phase 2 master protocol assessing plixorafenib for BRAF-altered cancers
Creators: Karisa C. Schreck - University of Baltimore
Macarena I. de la Fuente - University of Miami
Jessica Rine
Irina Kline
Stacie Peacock Shepherd
Jordi Rodon - The University of Texas MD Anderson Cancer Center
Rona Yaeger - Memorial Sloan Kettering Cancer Center
Eric Sherman - Memorial Sloan Kettering Cancer Center
Publication Details: Cancer research (Chicago, Ill.), Vol.85(8_Supplement_2), pp.CT247-CT247
Academic Unit: Miller School of Medicine; UMMG Department of Neurology; UMMG Dept of Neurology - Neuro-Oncology Div
Language: English
Resource Type: Journal article
Record Identifier: 991032662082502976